HBV PGRNA STATUS CAN REVEAL THE LONG-TERM PROGNOSES OF CHRONIC HEPATITIS B PATIENTS TREATED WITH NUCLEOS(T)IDE ANALOGUES

被引:0
|
作者
Luo, Hao [1 ]
Tan, Ning [1 ]
Kang, Qian [1 ]
Pan, Jiali [1 ]
Xu, Xiaoyuan [2 ]
机构
[1] Peking Univ, Hosp 1, Beijing, Peoples R China
[2] Peking Univ, Hosp 1, Infect Dis, Beijing, Peoples R China
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
651
引用
收藏
页码:408A / 408A
页数:1
相关论文
共 50 条
  • [21] HBV PGRNA DYNAMICS CHARACTERISTICS AMONG CHRONIC HEPATITIS B PATIENTS RECEIVING NUCLEOS(T)IDE ANALOGUE TREATMENT.
    Luo, Hao
    Xu, Jinghang
    Cheng, Ran
    Han, Yifan
    Kang, Qian
    Tan, Ning
    Pan, Jiali
    Chen, Hongyu
    Yang, Yuqing
    Xu, Xiaoyuan
    HEPATOLOGY, 2020, 72 : 442A - 443A
  • [22] HBsAg CLEARENCE AFTER LONG-TERM FOLLOW-UP IN CHRONIC HEPATITIS B PATIENTS TREATED WITH INTERFERON ALPHA AND NUCLEOS(T)IDE ANALOGUES
    Pinarbasi, B.
    Kaymakoglu, S.
    Akyuz, F.
    Issever, H.
    Ermis, F.
    Uyanikoglu, A.
    Baran, B.
    Hindilerden, F.
    Sumnu, A.
    Demir, K.
    Besisik, F.
    Cakaloglu, Y.
    Mungan, Z.
    Okten, A.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S332 - S332
  • [23] Chronic hepatitis B: peginterferon or nucleos(t)ide analogues?
    Sonneveld, Milan J.
    Janssen, Harry L. A.
    LIVER INTERNATIONAL, 2011, 31 : 78 - 84
  • [24] Treatment of chronic hepatitis B with nucleos(t)ide analogues
    Ohishi, Waka
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2012, 42 (03) : 219 - 225
  • [25] Long-term effect of nucleos (t)ide analogs on hepatitis B surface antigen in chronic hepatitis B patients
    Morikawa, Kenichi
    Umemura, Machiko
    Ogawa, Koji
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Kawagishi, Naoki
    Shimazaki, Tomoe
    Kimura, Megumi
    Izumi, Takaaki
    Nakai, Masato
    Sho, Takuya
    Suda, Goki
    Natsuizaka, Mitsuteru
    Ono, Kota
    Murata, Kazumoto
    Sugiyama, Masaya
    Masashi, Mizokami
    Sakamoto, Naoya
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E477 - E477
  • [26] Long-term outcome of hepatitis B virus-related Chronic Hepatitis under protracted nucleos(t)ide analogues
    Niro, G. A.
    Ippolito, A. M.
    Fontana, R.
    Valvano, M. R.
    Gioffreda, D.
    Iacobellis, A.
    Merla, A.
    Durazzo, M.
    Lotti, G.
    Di Mauro, L.
    Andriulli, A.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (07) : 502 - 509
  • [27] Considerations for the long-term treatment of chronic hepatitis B with nucleos(t)ide analogs
    Petersen, Joerg
    Buti, Maria
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (06) : 683 - 694
  • [28] Durability of Nucleos(t)ide Analogues Treatment in Patients With Chronic Hepatitis B
    Lee, I-Cheng
    Sun, Cheuk-Kay
    Su, Chien-Wei
    Wang, Yuan-Jen
    Chang, Hung-Chuen
    Huang, Hui-Chun
    Lee, Kuei-Chuan
    Huang, Yi-Shin
    Perng, Chin-Lin
    Liu, Yuh-Hwa
    Chua, Chian-Sem
    Lin, Yu-Min
    Lin, Han-Chieh
    Huang, Yi-Hsiang
    MEDICINE, 2015, 94 (32)
  • [29] Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?
    Kao, Jia--Horng
    Berg, Thomas
    GUT, 2019, 68 (12) : 2105 - 2106
  • [30] RISK OF HEPATOCELLULAR CARCINOMA IN CHRONIC HEPATITIS B TREATED WITH NUCLEOS(T)IDE ANALOGUES
    Yang, Q. L.
    Chong, T. Y.
    JOURNAL OF HEPATOLOGY, 2011, 54 : S407 - S407